InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Taylor Daphne. Officer active across 1 company, notably Aptevo Therapeutics Inc.. Cumulatively, 8 disclosures have been published. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Taylor Daphne has filed 6 filings in total. The 6 sampled filings, all relating to Aptevo Therapeutics Inc., run from 2023-03-07 to 2025-03-04, and the most frequent transaction nature is Levée d'options.